These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 10471566)

  • 1. Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives.
    Golenser J; Frankenburg S; Ehrenfreund T; Domb AJ
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2209-14. PubMed ID: 10471566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
    Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.
    Yardley V; Croft SL
    Antimicrob Agents Chemother; 1997 Apr; 41(4):752-6. PubMed ID: 9087483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.
    Gangneux JP; Sulahian A; Garin YJ; Derouin F
    Trans R Soc Trop Med Hyg; 1996; 90(5):574-7. PubMed ID: 8944278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel injectable water-soluble amphotericin B-arabinogalactan conjugate.
    Falk R; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1975-81. PubMed ID: 10428922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of amino-containing drugs to polysaccharides by tosylation: amphotericin B-arabinogalactan conjugates.
    Ehrenfreund-Kleinman T; Golenser J; Domb AJ
    Biomaterials; 2004 Jul; 25(15):3049-57. PubMed ID: 14967538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and
    Iman M; Huang Z; Alavizadeh SH; Szoka FC; Jaafari MR
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis.
    Jaafari MR; Hatamipour M; Alavizadeh SH; Abbasi A; Saberi Z; Rafati S; Taslimi Y; Mohammadi AM; Khamesipour A
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():156-165. PubMed ID: 31582344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Amphotericin B-Conjugated Functionalized Carbon Nanoparticles in the Treatment of Cutaneous Leishmaniasis.
    Heidari-Kharaji M; Guerra SS; Puneiad RP
    Parasite Immunol; 2024 Oct; 46(10):e13068. PubMed ID: 39363635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated healing of cutaneous leishmaniasis in non-healing BALB/c mice using water soluble amphotericin B-polymethacrylic acid.
    Corware K; Harris D; Teo I; Rogers M; Naresh K; Müller I; Shaunak S
    Biomaterials; 2011 Nov; 32(31):8029-39. PubMed ID: 21807409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.
    Gürbüz Çolak N; Çetin Uyanikgil EÖ; Özbel Y; Töz S
    Acta Parasitol; 2022 Sep; 67(3):1354-1363. PubMed ID: 35857275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of amphotericin b derivatives on Leishmania and immune functions.
    Ehrenfreund-Kleinman T; Domb AJ; Jaffe CL; Nasereddin A; Leshem B; Golenser J
    J Parasitol; 2005 Feb; 91(1):158-63. PubMed ID: 15856892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a new liposomal formulation of amphotericin B against two strains of Leishmania infantum in a murine model.
    Paul M; Durand R; Fessi H; Rivollet D; Houin R; Astier A; Deniau M
    Antimicrob Agents Chemother; 1997 Aug; 41(8):1731-4. PubMed ID: 9257750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic and hemolytic evaluation of in-situ liposomal preparation containing amphotericin - beta complexed with different chemically modified beta - cyclodextrins.
    Chakraborty KK; Naik SR
    J Pharm Pharm Sci; 2003; 6(2):231-7. PubMed ID: 12935435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.
    Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF
    Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection.
    Alsaadi M; Italia JL; Mullen AB; Ravi Kumar MN; Candlish AA; Williams RA; Shaw CD; Al Gawhari F; Coombs GH; Wiese M; Thomson AH; Puig-Sellart M; Wallace J; Sharp A; Wheeler L; Warn P; Carter KC
    J Control Release; 2012 Jun; 160(3):685-91. PubMed ID: 22516093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of amphotericin B-arabinogalactan conjugate in mouse tissue and its therapeutic efficacy against murine aspergillosis.
    Falk R; Grunwald J; Hoffman A; Domb AJ; Polacheck I
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3606-9. PubMed ID: 15328139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphotericin B-gum arabic conjugates: synthesis, toxicity, bioavailability, and activities against Leishmania and fungi.
    Nishi KK; Antony M; Mohanan PV; Anilkumar TV; Loiseau PM; Jayakrishnan A
    Pharm Res; 2007 May; 24(5):971-80. PubMed ID: 17372682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice.
    Nelson KG; Bishop JV; Ryan RO; Titus R
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1238-44. PubMed ID: 16569834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.
    Corral MJ; Serrano DR; Moreno I; Torrado JJ; Domínguez M; Alunda JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3268-74. PubMed ID: 25096077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.